ADCs & Engineered Antibodies Conferences
As ADCs strive to cement themselves as standard of care therapies and expand into harder to treat cancers, and engineered antibodies including bispecifics and T-cell engagers look to make an impact in solid tumors and autoimmune diseases, Hanson Wade strives to provide industry leading insights and connections to make this promise a reality.
0
Sponsors
0
Speakers
0
Attendees